ライフサイエンスコーパス: retinoic acid receptor

1 he regulation of gene expression through the retinoic acid receptor.

2 tivation with minimal cross-signaling of the retinoic acid receptor.

3 ioned close to the TSS, a process favored by retinoic acid receptors.

4 agocytic receptors including TG2 by ligating retinoic acid receptors.

5 ector responses through their binding to the retinoic acid receptor, a ligand-activated transcription

6 oncoprotein containing the C terminus of the retinoic acid receptor-a (RARa) fused to an N-terminal p

7 cal functions, including pregnane X receptor/retinoic acid receptor activation as a potential host an

8 ntifies cancer-specific effectors within the retinoic acid receptor activation pathway among the hype

9 stic relationship between AP1 expression and retinoic acid receptor activity, increased differentiati

10 ghted in the enantioselective synthesis of a retinoic acid receptor agonist and a fatty acid amide hy

11 d be reversed by the coadministration of the retinoic acid receptor agonist, all-trans-retinoic acid,

12 A dominant-negative form of the retinoic acid receptor alpha (DNhRARalpha) was expressed

13 in CD8(+) T cells using a dominant negative retinoic acid receptor alpha (dnRARalpha) established th

14 proteins, promyelocytic leukemia zinc finger-retinoic acid receptor alpha (PLZF-RARalpha) and RARalph

15 proteins, promyelocytic leukemia zinc finger-retinoic acid receptor alpha (PLZF-RARalpha) and RARalph

16 the expression of the promyelocytic leukemia-retinoic acid receptor alpha (PML-RAR-alpha) oncoprotein

17 tion that creates the promyelocytic leukemia-retinoic acid receptor alpha (PML-RARA) fusion oncogene.

18 es the fusion protein promyelocytic leukemia-retinoic acid receptor alpha (PML-RARA) in nearly all ca

19 ons produce a promyelocytic leukemia protein-retinoic acid receptor alpha (PML-RARalpha) fusion gene.

20 c leukemia specific promyelocytic locus gene-retinoic acid receptor alpha (PML-RARalpha) fusion prote

21 tic leukemia (APL), a promyelocytic leukemia-retinoic acid receptor alpha (PML-RARalpha) fusion prote

22 carrying leukemogenic promyelocytic leukemia-retinoic acid receptor alpha (PML-RARalpha) fusion prote

23 (APL) and the role of promyelocytic leukemia-retinoic acid receptor alpha (PML-RARalpha) in establish

24 The promyelocytic leukemia-retinoic acid receptor alpha (PML-RARalpha) protein of a

25 a (APL) cells express promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) fusion prote

26 is blocked by its dominant-negative form PML-retinoic acid receptor alpha (PMLRARalpha).

27 cytic leukemia (PML) protein is fused to the retinoic acid receptor alpha (RAR).

28 ranslocation, which results in fusion of the retinoic acid receptor alpha (RARA) gene to another gene

29 of the APL-associated fusion oncoprotein PML/retinoic acid receptor alpha (RARA).

30 hrough overexpression of a dominant negative retinoic acid receptor alpha (RARalpha) (dnRARalpha mice

31 dependent manners, which is mediated through retinoic acid receptor alpha (RARalpha) and retinoid X r

32 Here, we show that UTX interacts with the retinoic acid receptor alpha (RARalpha) and that this in

33 sable for spermatogenesis, and disruption of retinoic acid receptor alpha (RARalpha) function resulte

34 RARalpha, in which the PML gene fuses to the retinoic acid receptor alpha (RARalpha) gene.

35 through its fusion to the gene encoding the retinoic acid receptor alpha (RARalpha) in acute promyel

36 tinoic acid (ATRA) and other agonists of the retinoic acid receptor alpha (RARalpha) inhibit the form

37 Retinoic acid receptor alpha (RARalpha) is a transcripti

38 ML) nuclear bodies (NBs) mediated by the PML-retinoic acid receptor alpha (RARalpha) oncoprotein.

39 expression of a dominant-negative mutant of retinoic acid receptor alpha (RARalpha) specifically to

40 The retinoic acid receptor alpha (RARalpha) was recruited by

41 Retinoic acid receptor alpha (RARalpha) was the critical

42 rans retinoic acid, an activating ligand for retinoic acid receptor alpha (RARalpha), is used to trea

43 ed fusion transcription factor proteins (PML-retinoic acid receptor alpha and AML1-ETO), but it is al

44 ntly demonstrated for promyelocytic leukemia-retinoic acid receptor alpha and breakpoint cluster regi

45 ed FoxP3+ T cells is mediated by the nuclear retinoic acid receptor alpha and involves T cell activat

46 The levels of the retinoid receptors, retinoic acid receptor alpha and retinoid X receptor gam

47 Expression profiling of a retinoic acid receptor alpha coactivator protein, P/CAF,

48 Cytokines both potentiate retinoic acid receptor alpha expression and enhance its

49 esence of factors that interfere with proper retinoic acid receptor alpha function.

50 n, initially discovered as a part of the PML/retinoic acid receptor alpha fusion protein, has been fo

51 promyelocytic leukemia protein (PML) and PML-retinoic acid receptor alpha fusion protein.

52 NuMA-retinoic acid receptor alpha fusion proteins have been d

53 Here, we show that retinoic acid receptor alpha not only links retinoic aci

54 e progressive multifocal leukoencephalopathy/retinoic acid receptor alpha oncoprotein, in combination

55 c acid leads to degradation of promyelocytic-retinoic acid receptor alpha protein and disappearance o

56 I/RARalpha (cellular retinol-binding protein/retinoic acid receptor alpha) expression, and led to apo

57 RARA (retinoic acid receptor alpha) haploinsufficiency is an i

58 and exposure to retinoic acid (signaling via retinoic acid receptor alpha) increased alpha4beta7 expr

59 ex containing E26 transformation-specific 1, retinoic acid receptor alpha, and HATs (p300 and p300/cA

60 me proliferator-activated receptor alpha and retinoic acid receptor alpha, enabling a mild and leaky

61 Expression of a bcr-3 isoform of retinoic acid receptor alpha-promyelocytic leukemia (RAR

62 pression of the fusion protein promyelocytic-retinoic acid receptor alpha.

63 We demonstrated that the retinoic acid receptor alpha/retinoic X receptor alpha h

64 Knockdown of Kif7, and retinoic acid receptors alpha (Rara), beta (Rarb), and g

65 a role for the TFs estrogen receptor alpha, retinoic acid receptors alpha and gamma in breast cancer

66 The retinoic acid receptors alpha, beta and gamma (RARalpha,

67 We also demonstrate that the PML retinoic acid receptor-alpha (PML-RARalpha) oncofusion p

68 ssociation of promyelocytic leukemia protein-retinoic acid receptor-alpha (PML-RARalpha) with corepre

69 igenetic landscape of promyelocytic leukemia/retinoic acid receptor-alpha (PML-RARalpha)-associated a

70 PRKAR1A (R1A)-retinoic acid receptor-alpha (R1A-RARalpha) is the sixth

71 Retinoic acid receptor-alpha (RAR alpha) is a known estr

72 Translocations of the retinoic acid receptor-alpha (RARalpha) locus with the p

73 a was reduced by pharmacological blockade of retinoic acid receptor-alpha (RARalpha) signaling, indic

74 elective retinoids revealed that ligands for retinoic acid receptor-alpha (RARalpha), including atRA,

75 hesized that specific activation of a single retinoic acid receptor-alpha (RARalpha), without direct

76 s (LCL) were treated with AM580, a synthetic retinoic acid receptor-alpha agonist that upregulates CD

77 osomal translocations that generate chimeric retinoic acid receptor-alpha proteins (x-RARalpha fusion

78 Stimulation of the Sox9 and HoxA1 genes by retinoic acid receptor-alpha was found to require both D

79 erentiation and metabolism by activating the retinoic acid receptor and retinoid X receptor (RXR), in

80 cer therapy and that the expression level of retinoic acid receptor and RXR in tumors may be crucial

81 retinoids is mediated by retinoid receptors (retinoic acid receptors and retinoid X receptors), which

82 nctions in the body through specific nuclear retinoic-acid receptors and retinoid-X receptors, which

83 Furthermore, a pan retinoic acid receptor antagonist (AGN193109) could less

84 nt with an inhibitor of RA biosynthesis or a retinoic acid receptor antagonist increases gata1(+) ery

85 This process was inhibited by the retinoic acid receptor antagonist LE450, showing that it

86 iescence in PSCs via a mechanism involving a retinoic acid receptor beta (RAR-beta)-dependent downreg

87 ical avulsion, we show that treatment with a retinoic acid receptor beta (RARbeta) agonist results in

88 However, the level of retinoic acid receptor beta (RARbeta) and Nur77 (NR4A1)

89 Here we show that retinoic acid receptor beta (RARbeta) controls developme

90 Here, we identify a single target, neuronal retinoic acid receptor beta (RARbeta), which modulates t

91 volves repression of the RA-responsive gene, retinoic acid receptor beta (RARbeta), Wnt signals are w

92 ation and reexpression of the oncosuppressor retinoic acid receptor beta (RARbeta).

93 sion of retinoid homeostatic genes (encoding retinoic acid receptor beta [RARbeta], CYP26A1, and leci

94 ing E-cadherin, estrogen receptor alpha, and retinoic acid receptor beta and impaired tumor growth in

95 We have analysed the murine retinoic acid receptor beta gene (Rarb) and show that it

96 tion upstream of RARB (the gene that encodes retinoic acid receptor beta) had nominal genome-wide sig

97 SIRT1 deacetylates and coactivates the retinoic acid receptor beta, a known regulator of ADAM10

98 es by deacetylating the transcription factor retinoic acid receptor beta, a potential new therapeutic

99 authors present the crystal structure of the retinoic acid receptor beta-retinoic X receptor alpha (R

100 the quaternary architecture of multi-domain retinoic acid receptor beta-retinoic X receptor alpha (R

101 Retinoid-oral IEN studies (eg, of retinoic acid receptor-beta, p53, genetic instability, l

102 The expression of retinoic acid receptor beta2 (RAR-beta2) is frequently l

103 tly demonstrated that a transcription factor retinoic acid receptor beta2 (RARbeta2) promoted axonal

104 Here we tested the hypothesis that retinoic acid receptor beta2 (RARbeta2), critical in dev

105 es: glutathione S-transferase pi (GSTPi) and retinoic acid receptor beta2 (RARbeta2).

106 mental pollution) has been shown to suppress retinoic acid receptor-beta2 (RAR-beta(2)) and induce cy

107 f Ras association domain family 1 (RASSF1A), retinoic acid receptor-beta2 (RAR-beta2), and O6-methylg

108 ation of an epigenetic downregulation of the retinoic acid receptor-beta2 expression in CD34 cells, a

109 e heterodimers of T3 receptor (TR) and 9-cis-retinoic acid receptor bind to the TRE both in vitro and

110 utagenesis of five cis-acting element types (retinoic acid receptor binding elements [RARE], cyclic A

111 direct target of retinoic acid action, via a retinoic acid receptor binding site in the Epo gene enha

112 irus infection and cooperates with activated retinoic acid receptor binding sites to further promote

113 The retinoic acid receptor binds to highly compacted chromat

114 that the physical interface between SMRT and retinoic acid receptor can be a potential therapeutic ta

115 Iterated DNA binding sites for retinoic acid receptor, CREB, and NF-kappaB family membe

116 itor cells, SMRT was critical for preventing retinoic-acid-receptor-dependent induction of differenti

117 racts only at micromolar concentrations with retinoic acid receptor, does not activate retinoid-X rec

118 ctivation of PPARgamma, but not PPARalpha or retinoic acid receptors, effectively induced lipid accum

119 X receptor (cholesterol efflux to lumen) and retinoic acid receptor/farnesoid X receptor (cholesterol

120 ich degrade the promyelocytic leukemia (PML)-retinoic acid receptor fusion protein.

121 We provide evidence that the retinoic acid receptor gamma (RAR-G) plays a major role

122 We previously found that retinoic acid receptor gamma (RARgamma) agonist blocks h

123 Retinoic acid synthesis enzyme, RALDH2, and retinoic acid receptor gamma (RARgamma) are expressed in

124 Here we report that the cytoplasmic retinoic acid receptor gamma (RARgamma) controls recepto

125 A in a derived RA-resistant cell line with a retinoic acid receptor gamma (RARgamma) defect, but sens

126 Interestingly, overexpression of retinoic acid receptor gamma (RARgamma) strongly inhibit

127 Retinoic acid receptor gamma 2 (RARgamma2) is the major

128 , the authors show that the nuclear receptor retinoic acid receptor gamma is released from the nucleu

129 e (a retinoid X receptor agonist), CD1530 (a retinoic acid receptor gamma selective agonist), and the

130 arathyroid hormone-related protein receptor, retinoic acid receptor gamma, matrix metalloproteinase 1

131 The depletion of transcripts of retinoic-acid receptor gamma from oocytes increases oct4

132 The proteins include the retinoic-acid-receptor gamma, a known repressor of oct4

133 tially prevented in mice receiving a nuclear retinoic acid receptor-gamma (RAR-gamma) agonist.

134 rs of vitamin D receptor (VDR)/RXR-alpha and retinoic acid receptor-gamma (RAR-gamma)/RXR-beta are bo

135 Here, we showed that retinoic acid receptor-gamma (RARgamma) was cytoplasmic

136 d the signaling of retinoic acid through the retinoic acid receptor gene rarab.

137 described in animals lacking several of the retinoic acid receptor genes, or in animals exposed to e

138 , addition of all-trans-retinal did activate retinoic acid receptors in cultured cells.

139 PR also increased ACER2 expression through a retinoic acid receptor-independent and caspase-dependent

140 Retinoic acid via retinoic acid receptors induced expression of the intest

141 a antagonist or with retinoid X receptor and retinoic acid receptor ligands partially modulated apopt

142 l cholesterol homeostasis via two receptors: retinoic acid receptor/liver X receptor (cholesterol eff

143 Nuclear retinoic acid receptors mediate most but not all of the

144 DEAB treatment also caused a decrease in retinoic acid receptor-mediated signaling within human H

145 caused by an erroneous signaling mediated by retinoic acid receptors on the MMP-1 promoter and leads

146 imal expression changes were associated with retinoic acid receptor or vitamin D receptor heterodimer

147 we focus on the role of retinoid X receptor, retinoic acid receptor, peroxisome proliferator-associat

148 elastase (NE) cleaves promyelocytic leukemia-retinoic acid receptor (PML-RAR)alpha (PR), the fusion p

149 We identified several retinoic acid receptor (RAR) agonists that reduced secre

150 The retinoic acid receptor (RAR) alpha, beta(2), and gamma i

151 lter the effect of ATRA on the expression of retinoic acid receptor (RAR) alpha, beta, or gamma.

152 minantly formed in the presence of activated retinoic acid receptor (RAR) alpha, whereas motoneurons

153 nvestigated how the human (h) ADA3 regulates retinoic acid receptor (RAR) alpha-mediated transactivat

154 s direct further monocytic maturation, while retinoic acid receptor (RAR) and C/EBPepsilon direct gra

155 cription by activating the nuclear receptors retinoic acid receptor (RAR) and peroxisome proliferator

156 RA augmentation involved the binding of retinoic acid receptor (RAR) and retinoid X receptor (RX

157 ctivate TRAIL-R1 expression was inhibited by retinoic acid receptor (RAR) antagonists or siRNAs, but

158 We show here the role of retinoic acid receptor (RAR) beta and alpha signalling i

159 CYP26A1 and retinoic acid receptor (RAR) beta were found to be great

160 in neurite outgrowth in vitro, and that the retinoic acid receptor (RAR) beta2 is critical for this

161 Retinoic acid receptor (RAR) binds Ngn2 and is thereby r

162 ivity for RXR and minimal crossover onto the retinoic acid receptor (RAR) compared to all-trans-retin

163 RA is the ligand of the retinoic acid receptor (RAR) family of transcription fac

164 The retinoic acid receptor (RAR) gamma agonist CD1530 was as

165 We have previously shown that retinoic acid receptor (RAR) gamma-deficient mice have h

166 Nuclear receptors including retinoic acid receptor (RAR) have been proposed to play

167 s6 promoter is specifically activated by the retinoic acid receptor (RAR) in response to its natural

168 Here, we identify a new role for the retinoic acid receptor (RAR) in the anterior of the embr

169 ed dissect the intrinsic role of each of the retinoic acid receptor (RAR) isoforms in the clonal expa

170 eover, transgenic donor T cells expressing a retinoic acid receptor (RAR) response element luciferase

171 sion of lamin-A is known to be controlled by retinoic acid receptor (RAR) transcription factors, but

172 Activation of retinoic acid receptor (RAR) with all-trans-retinoic aci

173 luding Sonic hedgehog (Shh), Wingless (Wnt), retinoic acid receptor (RAR), and bone morphogenetic pro

174 multiple transcription factors that include retinoic acid receptor (RAR), associates with histone H3

175 ite adipocytes by selectively activating the retinoic acid receptor (RAR), recruiting the coactivator

176 The transcription factors retinoic acid receptor (RAR), retinoid X receptor (RXR),

177 d regulate gene expression by binding to the retinoic acid receptor (RAR), while 9-cis-retinoic acid

178 -cells by overexpressing a dominant-negative retinoic acid receptor (RAR)-alpha mutant (RARdn) using

179 ially due to the epigenetic silencing of the retinoic acid receptor (RAR)-beta The histone deacetylas

180 mice, potently induced BMP2 in WT MSCs in a retinoic acid receptor (RAR)-dependent manner, suggestin

181 We show that PARP-1 is indispensable to retinoic acid receptor (RAR)-mediated transcription from

182 interaction, AEG-1 profoundly inhibited RXR/retinoic acid receptor (RAR)-mediated transcriptional ac

183 While human ILCPs express low levels of retinoic acid receptor (RAR)-related orphan receptor C (

184 ediated suppression of the expression of the retinoic acid receptor (RAR)-related orphan receptor gam

185 Tconv and Treg express similar levels of the retinoic acid receptor (RAR).

186 transport RA from the cytosol to the nuclear retinoic acid receptor (RAR).

187 However, RA did not use the conventional retinoic acid receptor (RAR)/retinoid X receptor (RXR) t

188 roteins such as promyelocytic leukemia (PML)-retinoic acid receptor (RAR)alpha and promyelocytic leuk

189 Notably, the expression of retinoic acid receptor (RAR-beta) and retinoid X recepto

190 id (ATRA), on gene transcription mediated by retinoic acid receptors (RAR) and retinoic acid response

191 Podocytes expressed most isoforms of retinoic acid receptors (RAR) and retinoid X receptors (

192 4-HBR is shown to exhibit binding to the retinoic acid receptors (RAR) at concentrations necessar

193 sms by which progesterone receptors (PR) and retinoic acid receptors (RAR) regulate CK5 expression an

194 ty of distinct transcription factors such as retinoic acid receptors (RAR), peroxisome-proliferator-a

195 ABP2), fatty acid-binding protein 5 (FABP5), retinoic acid receptors (RAR-alpha, -beta, -gamma), and

196 otein between a tumor suppressor PML and the retinoic acid receptor RARalpha.

197 15;17) chromosomal translocation which fuses retinoic acid receptor (RARalpha) to PML is almost alway

198 riptional signaling, including reductions in retinoic acid receptor (RARalpha, RARbeta2 and RARgamma)

199 is also a high-affinity antagonist of all 3 retinoic acid receptors (RARalpha, RARbeta, and RARgamma

200 NA sequence derived from the promoter of the retinoic acid receptor (RARE) gene.

201 sibility using the ligand binding domains of retinoic acid receptor (RARLBD) and of retinoid X recept

202 The retinoic acid receptors (RARs or rars) and the thyroid h

203 Retinoic acid receptors (RARs) alpha, beta and gamma are

204 lability of nuclear hormone receptors called retinoic acid receptors (RARs) and retinoid receptors (R

205 somer, 9-cis-retinoic acid (9cRA), activates retinoic acid receptors (RARs) and retinoid X receptors

206 Retinoic acid receptors (RARs) and retinoid X receptors

207 se retinoids are mediated through members of retinoic acid receptors (RARs) and retinoid X receptors.

208 acting motifs and selectively interacts with retinoic acid receptors (RARs) and rexinoid receptor (RX

209 Retinoic acid receptors (RARs) are members of the nuclea

210 ession due to AP-1 inhibition resulting from retinoic acid receptors (RARs) competing for limiting am

211 Retinoic acid receptors (RARs) heterodimerize with retin

212 r to explore the paracrine role of adipocyte retinoic acid receptors (RARs) in mammary morphogenesis.

213 ge organ of vitamin A, but activation of the retinoic acid receptors (RARs) in mouse liver and in hum

214 Retinoic acid receptors (RARs) mediate RA effects by dir

215 called nuclear receptors, which includes the retinoic acid receptors (RARs) responsible for mediating

216 In this study, we target specific retinoic acid receptors (RARs) to either PD duplicate (R

217 al cofactor that directly interacts with the retinoic acid receptors (RARs) to modulate retinoic acid

218 noic acid leads to activation and binding of retinoic acid receptors (RARs) to the Hox1-Hox5 chromati

219 igand-activated transcription factors termed retinoic acid receptors (RARs), but this hormone can als

220 1 (TNIP1) is a corepressor of agonist-bound retinoic acid receptors (RARs).

221 family of nuclear transcription factors, the retinoic acid receptors (RARs).

222 l profile limited primarily to activation of retinoic acid receptors (RARs).

223 r family of transcription factors, including retinoic acid receptors (RARs).

224 activities that are mediated by the nuclear retinoic acid receptors (RARs).

225 to express sufficient amounts of endogenous retinoic acid receptors (RARs).

226 es gene transcription via binding to nuclear retinoic acid receptors (RARs).

227 found that HCV-specific IL-17-producing and retinoic acid receptor related orphan receptorgammat-exp

228 Retinoic acid receptor-related orphan nuclear receptor a

229 Adalimumab therapy led to a reduction in retinoic acid receptor-related orphan nuclear receptor C

230 gh small-molecule thymus-specific isoform of retinoic acid receptor-related orphan nuclear receptor g

231 TGF-beta had no effect on the expression of retinoic acid receptor-related orphan nuclear receptor g

232 nd blocking antibodies in mice, we show that retinoic acid receptor-related orphan nuclear receptor g

233 cells are distinguished by expression of the retinoic acid receptor-related orphan nuclear receptor R

234 fy STAT3-induced transcription of IL-17A and retinoic acid receptor-related orphan nuclear receptor,

235 gival expressions of interleukin (IL)-17 and retinoic acid receptor-related orphan receptor (ROR) gam

236 synergizes with IL-1beta and IL-23 to drive retinoic acid receptor-related orphan receptor (ROR)-gam

237 and activators of transcription (STAT)3 and retinoic acid receptor-related orphan receptor (ROR)-gam

238 Herein, we show that FOXP3 interacts with retinoic acid receptor-related orphan receptor (ROR)alph

239 Here we showed that retinoic acid receptor-related orphan receptor alpha (RO

240 rcadian expression of BMAL1 is influenced by retinoic acid receptor-related orphan receptor alpha (RO

241 of Molecular Cell, Lee et al. show that the retinoic acid receptor-related orphan receptor alpha (RO

242 n this study, we demonstrate that the 730 kb retinoic acid receptor-related orphan receptor alpha (RO

243 on in CRP in EAs (P </= 6.8 x 10(-4)) and in retinoic acid receptor-related orphan receptor alpha (RO

244 d receptor-related orphan receptor C [RORC], retinoic acid receptor-related orphan receptor alpha [RO

245 Retinoic acid receptor-related orphan receptor C (RORc,

246 TH17 lineage (retinoic acid receptor-related orphan receptor C [RORC],

247 an Th17 cells by enhancing the expression of retinoic acid receptor-related orphan receptor C through

248 Here we show that retinoic acid receptor-related orphan receptor gamma (RO

249 Retinoic acid receptor-related orphan receptor gamma (RO

250 esolution to this issue, we demonstrate that retinoic acid receptor-related orphan receptor gamma (RO

251 tor gamma(-/-) T cells by MSCs revealed that retinoic acid receptor-related orphan receptor gamma is

252 T cells and GATA-binding protein 3 (but not retinoic acid receptor-related orphan receptor gamma or

253 sion of Foxp3(+) T(reg) cell generation from retinoic acid receptor-related orphan receptor gamma(-/-

254 Moreover, STAT3 regulated the expression of retinoic acid receptor-related orphan receptor gamma-T (

255 Th17 cells with characteristic expression of retinoic acid receptor-related orphan receptor gamma-t (

256 s response is driven by the master regulator retinoic acid receptor-related orphan receptor gammat (R

257 decrease in STAT3 phosphorylation as well as retinoic acid receptor-related orphan receptor gammaT (R

258 In addition, the level of retinoic acid receptor-related orphan receptor gammat mR

259 on and intracellular expression of IL-17 and retinoic acid receptor-related orphan receptor gammat) w

260 beta into GF mice induces the development of retinoic acid receptor-related orphan receptor gammat-ex

261 -17 production and coexpression of GATA3 and retinoic acid receptor-related orphan receptor gammat.

262 the biology surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RO

263 ivo, despite relatively normal expression of retinoic acid receptor-related orphan receptor-gammaT (R

264 levels of IL-17A, IL-17F, IL-22, CCL-20, and retinoic acid receptor-related orphan receptor-gammat mR

265 Retinoic acid receptor-related orphan receptor-gammat-po

266 Retinoic acid receptor-related orphan receptors (RORs) r

267 ence for one family of orphan receptors, the retinoic acid receptor-related orphan receptors (RORs),

268 The retinoic acid receptor-related orphan receptors alpha an

269 The retinoic acid receptor-related orphan receptors RORalpha

270 Retinoic acid receptor-related receptor alpha (RORalpha)

271 me proliferator-activated receptor alpha and retinoic acid receptor-related receptor alpha, RAR may a

272 Retinoic-acid-receptor-related orphan receptor alpha (RO

273 We show that loss of retinoic-acid-receptor-related orphan receptor-gammat-po

274 The nuclear receptors retinoic-acid-receptor-related orphan receptors alpha an

275 ributable to high dependence of promoters of retinoic-acid-receptor-related orphan receptors on the C

276 could be rescued by exogenous expression of retinoic-acid-receptor-related orphan receptors or a con

277 Ligand-activated retinoic acid receptors repressed Nur77 induction and fu

278 , the retinoic acid-induced tumor suppressor retinoic acid receptor responder 1 (RARRES1) has no know

279 Retinoic acid receptor responder 2 (RARRES2) is transcri

280 pothalamic ependymal cells, such as Rarres2 (retinoic acid receptor responder [tazarotene induced] 2)

281 trans retinoic acid (RA), through binding to retinoic acid receptor-retinoid X receptor (RAR-RXR) het

282 ha and p300 at the proximal promoter recruit retinoic acid receptor/retinoid X receptor from a distal

283 rans-13,14-dihydroretinoic acid can activate retinoic acid receptor/retinoid X receptor heterodimers

284 id not; RA increased the expression of known retinoic acid receptor/retinoid X receptor target genes,

285 on as homo- or heterodimers such as TR:9-cis retinoic acid receptor (RXR).

286 e elements led to a high affinity binding of retinoic acid receptor/RXR heterodimer to the retinoic a

287 are compromised in mouse embryos lacking the retinoic acid receptor RXRalpha.

288 d are key molecules that target retinoid and retinoic acid receptors (RXRs and RARs), leading to phys

289 Finally, by using retinoic acid receptor selective agonists we show that t

290 ar, we demonstrate that MLL2 participates in retinoic acid receptor signaling by promoting retinoic a

291 bopoietin (Tpo) gene as a target of the SMRT-retinoic acid receptor signaling pathway in bone marrow

292 The retinoid increase drives intrinsic retinoic acid receptor signaling, and activation occurs

293 set of vertebrate transcription factors, the retinoic acid receptor superfamily.

294 monji-domain containing gene JMJD3, a direct retinoic-acid-receptor target that functions as a histon

295 All-trans RA binds to its nuclear retinoic acid receptors that are expressed in lymphoid c

296 These transcription factors are the retinoic acid receptor, the retinoid X receptor, the hep

297 n in the early fetal liver: ligand-activated retinoic acid receptors, the hypoxia-regulated factor HI

298 virus expressing a dominant negative form of retinoic acid receptor type alpha blocks the reappearanc

299 erestingly, although the unliganded TR/9-cis-retinoic acid receptor was able to recruit corepressors

300 with Nr2f2, p300 (also known as Ep300) and a retinoic acid receptor, which is recruited to the retino